Last reviewed · How we verify
Acute relief of angina pectoris due to coronary artery disease
Approved treatments
- NITROGLYCERIN
Nitroglycerin forms nitric oxide, which activates guanylate cyclase, leading to increased cyclic GMP and subsequent vasodilation in smooth muscle.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute relief of angina pectoris due to coronary artery disease patent landscape — cliff calendar, originator estates, attackable patents
- Acute relief of angina pectoris due to coronary artery disease treatment landscape brief
- Acute relief of angina pectoris due to coronary artery disease treatment updates RSS
Frequently asked questions about Acute relief of angina pectoris due to coronary artery disease
What drugs treat Acute relief of angina pectoris due to coronary artery disease?
Tracked treatments include NITROGLYCERIN.
What is the treatment for Acute relief of angina pectoris due to coronary artery disease?
Standard treatment for Acute relief of angina pectoris due to coronary artery disease includes NITROGLYCERIN. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute relief of angina pectoris due to coronary artery disease patent cliff · Acute relief of angina pectoris due to coronary artery disease CI report
- Treatment: NITROGLYCERIN
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing